semaglutide and kidney stones Is it safe for a patient with a history of adequate renal function (eGFR ≥ 30 mL/min/1.73 m²) to start Ozempic (semaglutide)? Study crystallizes distinct kidney benefits

tirzepatide trials (Zepbound) reported up to 22% loss

These metabolic gains can persist for months after treatment, and continuing therapy helps prevent the metabolic decline that leads to weight regain

While this rapid evolution toward multi-agonist strategies and oral formulations promises enhanced efficacy, tolerability, and adherence, generating robust long-term safety and efficacy evidence remains imperative

Introduction Once considered a niche therapeutic area, obesity treatment has now become a strategic frontier for innovation, investment, and healthcare reform

The lower starting dose helps minimize the risk of side effects, especially gastrointestinal symptoms like nausea or upset stomach

.,Sanchis-ChordJ,Del PulgarEMG,Carrasco-LunaJ,Bentez-PezA,SanzYCodoer-FranchPBifidobacterium pseudocatenulatum CECT 7765 supplementation improves inflammatory status in insulin-resistant obese children.2019;58(7):27892800 68